findmyKOL
Clinical trialNCT00756730CompletedPhase 4Interventional

Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r

SponsorCommunity Research Initiative of New EnglandEnrollment49HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

For participants with HIV taking either lopinavir or fosamprenavir who have elevated triglycerides, this trial will study the change in triglycerides after switching protease inhibitors.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Spectrum Medical Group

    Phoenix, Arizona, United States

  • Aids Healthcare Foundation

    Los Angeles, California, United States

  • Orlando Immunology Center

    Orlando, Florida, United States

  • Community Research Initiative

    Boston, Massachusetts, United States

  • Community Research Initiative - West

    Springfield, Massachusetts, United States

  • Abbott Northwestern Infectious Disease and Travel Clinic

    Minneapolis, Minnesota, United States

  • Aids Community Health Center

    Rochester, New York, United States

  • Philadelphia Fight

    Philadelphia, Pennsylvania, United States

  • David M. Lee, M.D., P.A., A/b/a Uptown Physicians Group

    Dallas, Texas, United States

  • Nicholaos C. Bellos, Md, Pa

    Dallas, Texas, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

ATV/rDRV/r
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2008
Primary completion
30 Jun 2011
Completion
30 Jun 2011
Last update posted
21 Aug 2017
Registered enrollment
49
Registry id
NCT00756730

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.